Who
D. Scott Coward
Director
Company insider
Files Form 4 as: Director, Humacyte; Chief Legal Officer, Exact Sciences.
In numbers
- Trades disclosed
- 174
- Buys
- 0
- Sells
- 43
- Bought
- $0
- Sold
- $26.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 1 Jan 2015
- Last trade
- 6 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 7 Oct 2026 | HUMA Humacyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact SciencesDiagnostics & Labs | SEC FORM 4 Code D | —52,164 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact SciencesDiagnostics & Labs | SEC FORM 4 Code D | —5,398 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact SciencesDiagnostics & Labs | SEC FORM 4 Code D | —4,694 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative | SEC FORM 4 Code D | —4,175 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative | SEC FORM 4 Code D | —10,786 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative | SEC FORM 4 Code D | —12,875 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —4,175 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —10,786 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code D | —12,875 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciences | SEC FORM 4 Code D | —52,164 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciences | SEC FORM 4 Code D | —5,398 | filing |
| 23 Mar 2026filed 23 Mar 2026 | Exact Sciences | SEC FORM 4 Code D | —4,694 | filing |
| 12 Jun 2025filed 16 Jun 2025 | Exact Sciences | SEC FORM 4 Code A | —5,398 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | Exact Sciencesoption or derivative | SEC FORM 4 Code M | —2,248 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | Exact Sciences | SEC FORM 4 Code M | —2,248 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | Exact Sciences | SEC FORM 4 Code F | $33K667 at $49.63 | filing |
| 13 Jun 2024filed 20 Dec 2024 | Exact Sciences | SEC FORM 4 Code A | —5,939 at $0.00 | filing |
| 13 Jun 2024filed 17 Jun 2024 | Exact Sciences | SEC FORM 4 Code A | —5,444 at $0.00 | filing |
| 1 May 2024filed 2 May 2024 | Exact Sciences | SEC FORM 4 Sold | $4,03067 at $60.15 | filing |
News
No headline names them, or the companies they trade most, lately.